Insider Transactions in Q1 2024 at Ranpak Holdings Corp. (PACK)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 19
2024
|
Eric Laurensse Managing Director, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
5,896
-3.31%
|
$41,272
$7.35 P/Share
|
|
Mar 19
2024
|
William Drew Chief Financial Officer & SVP |
SELL
Payment of exercise price or tax liability
|
Direct |
4,340
-0.85%
|
$30,380
$7.35 P/Share
|
|
Mar 19
2024
|
Omar Asali CEO and Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
10,924
-0.41%
|
$76,468
$7.35 P/Share
|
|
Mar 19
2024
|
Mark A. Siebert MD, North America |
SELL
Payment of exercise price or tax liability
|
Direct |
3,946
-4.3%
|
$27,622
$7.35 P/Share
|
|
Mar 19
2024
|
Michael S. Gliedman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,480
-1.92%
|
$17,360
$7.35 P/Share
|
|
Mar 14
2024
|
Antonio Grassotti Managing Director, APAC |
BUY
Grant, award, or other acquisition
|
Direct |
20,730
+12.13%
|
-
|
|
Mar 14
2024
|
Mark A. Siebert MD, North America |
BUY
Grant, award, or other acquisition
|
Direct |
29,484
+24.3%
|
-
|
|
Mar 14
2024
|
Eric Laurensse Managing Director, Europe |
BUY
Grant, award, or other acquisition
|
Direct |
35,725
+16.71%
|
-
|
|
Mar 14
2024
|
Michael S. Gliedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,862
+12.13%
|
-
|
|
Mar 14
2024
|
Omar Asali CEO and Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
93,777
+3.42%
|
-
|
|
Mar 14
2024
|
William Drew Chief Financial Officer & SVP |
BUY
Grant, award, or other acquisition
|
Direct |
31,258
+5.75%
|
-
|
|
Mar 06
2024
|
William Drew Chief Financial Officer & SVP |
SELL
Payment of exercise price or tax liability
|
Direct |
4,859
-1.0%
|
$19,436
$4.55 P/Share
|
|
Mar 06
2024
|
Omar Asali CEO and Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
14,053
-0.55%
|
$56,212
$4.55 P/Share
|
|
Mar 06
2024
|
Michael S. Gliedman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,777
-2.43%
|
$11,108
$4.55 P/Share
|
|
Mar 06
2024
|
Eric Laurensse Managing Director, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
6,600
-4.43%
|
$26,400
$4.55 P/Share
|
|
Mar 06
2024
|
Michael Anthony Jones Director |
SELL
Payment of exercise price or tax liability
|
Direct |
14,402
-6.35%
|
$57,608
$4.55 P/Share
|
|
Mar 05
2024
|
Antonio Grassotti Managing Director, APAC |
BUY
Grant, award, or other acquisition
|
Direct |
20,343
+13.58%
|
-
|
|
Mar 05
2024
|
Mark A. Siebert MD, North America |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+24.73%
|
-
|
|
Mar 05
2024
|
William Drew Chief Financial Officer & SVP |
BUY
Grant, award, or other acquisition
|
Direct |
30,675
+5.94%
|
-
|
|
Mar 05
2024
|
Omar Asali CEO and Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
92,026
+3.46%
|
-
|
|
Mar 05
2024
|
Michael S. Gliedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,528
+13.29%
|
-
|
|
Mar 05
2024
|
Eric Laurensse Managing Director, Europe |
BUY
Grant, award, or other acquisition
|
Direct |
35,058
+19.05%
|
-
|
|
Jan 02
2024
|
Michael Anthony Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,222
+1.4%
|
$16,110
$5.43 P/Share
|
|
Jan 02
2024
|
K. El Pamela Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,222
+4.24%
|
$16,110
$5.43 P/Share
|
|
Jan 02
2024
|
Kurt Zumwalt Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,222
+4.22%
|
$16,110
$5.43 P/Share
|
|
Jan 02
2024
|
Alicia M. Tranen Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,222
+1.57%
|
$16,110
$5.43 P/Share
|
|
Jan 02
2024
|
Salil Seshadri Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,222
+0.67%
|
$16,110
$5.43 P/Share
|